Minnesota SF 831: Prescription drug manufacturer importation pathway plan application and incentives

Status: Comm report: To pass and re-referred to Health and Human Services Finance and Policy (as of 2021-03-17)

State: Minnesota · Session: 2021-2022 · Bill: SF 831

Subjects: Drugs and Medicine, Health and Health Department

Sponsors: Benson, Coleman, Dahms, Draheim, Kiffmeyer

View Minnesota SF 831 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.